Formulation and Delivery
Jagbir Singh, PhD
Director of Pre-Clinical Services
Precision NanoSystems
Vancouver, British Columbia, Canada
Description: Nucleic acids (e.g., siRNA, mRNA and saRNA) can be designed and formulated to silence, express, and edit specific genes providing a flexible and powerful approach to preventing and treating diseases. The recent commercialization and widespread distribution of COVID-19 mRNA vaccines has exemplified the massive potential to rapidly develop and scale-up new genomic medicines for applications beyond viral threats. Our BioPharma Services Team can de-risk and accelerate the development of promising RNA-LNP drug candidates for clinical evaluation and successful commercialization.